Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder

Intermittent Explosive Disorder Clinical Trial

Official title:
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Intermittent Explosive Disorder (IED)

Status Terminated

Clinical Trial Summary

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate AVP-786 for the treatment of Intermittent Explosive Disorder (IED).

Clinical Trial Description

Eligible participants for this study must have a diagnosis of current IED. This is a multicenter, randomized, double-blind, placebo-controlled study, consisting of up to 12 weeks of treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03420222
Study type	Interventional
Source	Otsuka Pharmaceutical Development & Commercialization, Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	January 18, 2018
Completion date	December 28, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06118567` - Effect of Nitrous Oxide on Aggression.	Phase 2
Terminated	`NCT00282165` - Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order	Phase 4
Not yet recruiting	`NCT04819230` - A Cognitive Bias Modification RCT for Aggression	N/A
Completed	`NCT02055638` - Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder	Phase 1/Phase 2
Completed	`NCT00078754` - A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder	Phase 2
Completed	`NCT00399698` - Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.	Phase 3
Recruiting	`NCT06118580` - Neural Correlates During Alcohol Intoxication	Phase 2
Completed	`NCT02048241` - Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder	Phase 4
Not yet recruiting	`NCT05895513` - Pimavanserin and Aggression and Social Cognition.	Phase 2
Recruiting	`NCT06275607` - Maladaptive Anger Treatment	N/A
Completed	`NCT00127400` - A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED	Phase 2
Completed	`NCT00667212` - Psychotherapy for Intermittent Explosive Disorder	Phase 2